Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Licai He

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Cancer Cell International|December 26, 2022
Therapeutic effect of a MUC1-specific monoclonal antibody-drug conjugates against pancreatic cancer modelGuang Wu, Lan Li, Mengnan Liu, et al.
Cellular & Molecular Immunology|November 9, 2019
LILRB4 ITIMs mediate the T cell suppression and infiltration of acute myeloid leukemia cellsZunling Li, Mi Deng, Fangfang Huang, et al.
Cellular & Molecular Immunology|February 2, 2020
Correction to: LILRB4 ITIMs mediate the T cell suppression and infiltration of acute myeloid leukemia cellsZunling Li, Mi Deng, Fangfang Huang, et al.
Cancer Science|July 27, 2020
24-Dehydrocholesterol reductase promotes the growth of breast cancer stem-like cells through the Hedgehog pathwayTing Qiu, Jiawei Cao, Wanzhou Chen, et al.
Biological Chemistry|March 1, 2024
KCTD5 regulates Ikaros degradation induced by chemotherapeutic drug etoposide in hematological cellsLan Ma, Changqing Yin, Yi Zhang, et al.
Journal of Leukocyte Biology|March 4, 2020
Primaquine phosphate induces the apoptosis of ATRA-resistant acute promyelocytic leukemia cells by inhibition of the NF-κB pathwayLan Ma, Lianjuan Chen, Haoying Li, et al.
Cancer Cell International|December 15, 2023
PRRG4 regulates mitochondrial function and promotes migratory behaviors of breast cancer cells through the Src-STAT3-POLG axisYang Wang, Jieyi Wang, Lan Chen, et al.
Oncogene|October 10, 2020
PRRG4 promotes breast cancer metastasis through the recruitment of NEDD4 and downregulation of Robo1Lingling Zhang, Yaqian Qin, Guang Wu, et al.
Journal of Translational Medicine|June 17, 2026
A novel therapeutic monoclonal antibody targeting PZR demonstrates potent anti-metastatic efficacy in triple-negative breast cancerJiayu Chen, Jiayi Shao, Ju Huang, et al.
Scientific Reports|November 8, 2017
Targeting Androgen Receptor in Treating HER2 Positive Breast CancerLicai He, Zhuanyun Du, Xusheng Xiong, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Cancer Cell International|December 26, 2022
Therapeutic effect of a MUC1-specific monoclonal antibody-drug conjugates against pancreatic cancer modelGuang Wu, Lan Li, Mengnan Liu, et al.
Cellular & Molecular Immunology|November 9, 2019
LILRB4 ITIMs mediate the T cell suppression and infiltration of acute myeloid leukemia cellsZunling Li, Mi Deng, Fangfang Huang, et al.
Cellular & Molecular Immunology|February 2, 2020
Correction to: LILRB4 ITIMs mediate the T cell suppression and infiltration of acute myeloid leukemia cellsZunling Li, Mi Deng, Fangfang Huang, et al.
Cancer Science|July 27, 2020
24-Dehydrocholesterol reductase promotes the growth of breast cancer stem-like cells through the Hedgehog pathwayTing Qiu, Jiawei Cao, Wanzhou Chen, et al.
Biological Chemistry|March 1, 2024
KCTD5 regulates Ikaros degradation induced by chemotherapeutic drug etoposide in hematological cellsLan Ma, Changqing Yin, Yi Zhang, et al.
Journal of Leukocyte Biology|March 4, 2020
Primaquine phosphate induces the apoptosis of ATRA-resistant acute promyelocytic leukemia cells by inhibition of the NF-κB pathwayLan Ma, Lianjuan Chen, Haoying Li, et al.
Cancer Cell International|December 15, 2023
PRRG4 regulates mitochondrial function and promotes migratory behaviors of breast cancer cells through the Src-STAT3-POLG axisYang Wang, Jieyi Wang, Lan Chen, et al.
Oncogene|October 10, 2020
PRRG4 promotes breast cancer metastasis through the recruitment of NEDD4 and downregulation of Robo1Lingling Zhang, Yaqian Qin, Guang Wu, et al.
Journal of Translational Medicine|June 17, 2026
A novel therapeutic monoclonal antibody targeting PZR demonstrates potent anti-metastatic efficacy in triple-negative breast cancerJiayu Chen, Jiayi Shao, Ju Huang, et al.
Scientific Reports|November 8, 2017
Targeting Androgen Receptor in Treating HER2 Positive Breast CancerLicai He, Zhuanyun Du, Xusheng Xiong, et al.
Pageof 3